Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycystic Ovary Syndrome × Interleukin 1 Receptor Antagonist Protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 4 Mucositis 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell 2 Febrile Neutropenia 2 Cytokine Release Syndrome 2 Burkitt Lymphoma 2 Smoldering Multiple Myeloma 1 Recurrence 1 Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Hematologic Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Metformin 122 Clomiphene 39 Letrozole 32 Inositol 24 Progesterone 15 Folic Acid 15 Exercise 14 drospirenone and ethinyl estradiol combination 12 Ethinyl Estradiol 12 Caloric Restriction 12 Estradiol 11 Contraceptives, Oral 11 cetrorelix 10 Chorionic Gonadotropin 10 Triptorelin Pamoate 9 Pioglitazone 9 Tablets 8 Spironolactone 8 High-Intensity Interval Training 8 Diet 8 Cholecalciferol 8 Menotropins 7 Gonadotropins 7 Acupuncture Therapy 7 drospirenone 6 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Flutamide 6 Exenatide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03578497 2021-01-27

FertIL

University Hospital, Basel, Switzerland

Phase 2 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡